Rchr
J-GLOBAL ID:200901009829701940
Update date: Sep. 19, 2024
Toi Masakazu
トイ マサカズ | Toi Masakazu
Affiliation and department:
Research field (1):
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (19):
- 2023 - 2028 SR-PETによる各種腫瘍のSSTR発現評価とPRRT適応可能性の検証
- 2019 - 2022 間質応答を利用したホルモン受容体陽性乳がんの治療戦略の構築
- 2018 - 2021 Development of breast cancer serum diagnostic method using NMR measurement based on a new concept
- 2016 - 2020 Development of advanced photoacoustic imaging system based on integration of optics and ultrasound and control of optical phase space
- 2016 - 2019 Epigenetic profiling of cfDNA in breast cancer samples
- 2015 - 2018 Study on quality, usefulness and ELSI of genetic testing including NGS analysis.
- 2013 - 2016 Ultrasound viscoelastography: development of quantitative imaging of tissue viscoelasticity based on fusion of static and dynamic tissue excitation
- 2012 - 2016 Biological optimal dosing of anti-neoplastic in order to maximize therapeutic efficacy and safety
- 2012 - 2016 Molecular mechanism in direct effect of VEGF onto breast cancer cells
- 2014 - 2015 Development of new breast cancer detection method by the serous samples
- 2012 - 2015 Evaluation of quality and usefullness of genetics testing-clinical application of next generation sequencer.
- 2012 - 2015 Bayesian study designs for new drug development in early-stage cancer clinical trials.
- 2010 - 2012 Development of advanced bioimaging technology based on integration of optics and ultrasound by spatio-temporal modulation
- 2009 - 2011 Research on functional analysis of circulating tumor cells in association with cancer metastasis.
- 2008 - 2010 Application of microRNA profilling to breast cancer diagnosis and therapy
- 2007 - 2008 蛋白多項目解析の基盤技術確立と臨床応用
- 2007 - 2008 Analysis and clinical application of normal blood vessel inducement by Int6-siRNA
- 1989 - 1990 Studies on the Scoring System of Diagnosis Using Thermography for Breast Cancer and its Clinical Application
- -
Show all
Papers (832):
-
Akane Higami, Masahiro Takada, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Kosuke Kawaguchi, Ayane Yamaguchi, Yasuhide Takeuchi, Yosuke Yamada, Masakazu Toi. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients. International Journal of Clinical Oncology. 2024
-
Yurina Maeshima, Tatsuki R Kataoka, Alexis Vandenbon, Masahiro Hirata, Yasuhide Takeuchi, Yutaka Suzuki, Yukiko Fukui, Masahiro Kawashima, Masahiro Takada, Yumiko Ibi, et al. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals a reduction in CD169+ macrophages within metastatic breast cancers. EBioMedicine. 2024. 107. 105271-105271
-
Tomoko Izawa, Ami Kobayashi, Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Akiyoshi Nakakura, Yuki Kataoka, Kenichiro Shide, Yukiko Mori, Kazuhiro Yamazaki, Masakazu Toi, et al. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study. BMC women's health. 2024. 24. 1. 165-165
-
Eriko Tokunaga, Yasuo Miyoshi, Koji Dozono, Tsutomu Kawaguchi, Masakazu Toi. Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial. The oncologist. 2024. 29. 3. e319-e329
-
Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, et al. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines. Breast cancer (Tokyo, Japan). 2024
more...
MISC (450):
-
弓削瞬介, 三宅可奈江, 高田正泰, 志水陽一, 北野香雪, 片岡正子, 石守崇好, 川島雅央, 河口浩介, 戸井雅和, et al. 浸潤性小葉癌におけるF-18FES PETの有用性. 核医学(Web). 2023. 60. Supplement
-
三宅可奈江, 高田正泰, 志水陽一, 弓削瞬介, 北野香雪, 石守崇好, 片岡正子, 板垣孝治, 川島雅央, 戸井雅和, et al. De novo ER陽性乳癌における[F-18]-FES PETの診断能:全身PET/CTと乳房PET/MRの比較. 核医学(Web). 2023. 60. Supplement
-
橋本陽菜, 片岡正子, 藤本晃司, 藤本晃司, 飯間麻美, 飯間麻美, 戸井雅和, 川瀬貫互, 大橋茜, 大橋茜, et al. Quantification of Tumor-Related Vessel Length on UF-DCE MRI and Their Association with Breast Cancer Subtypes [Presidential Award Proceedings]. 日本磁気共鳴医学会雑誌(Web). 2023. 43. 2
-
弓削瞬介, 三宅可奈江, 片岡正子, 八上全弘, 磯田裕義, 石守崇好, 松本純明, 高田正泰, 戸井雅和, 中本裕士. 任意型検診における乳房専用PETの診断能-初診群と再診群による比較-. 核医学(Web). 2022. 59. Supplement
-
太田理恵, 片岡正子, 飯間麻美, 三宅可奈江, 大野文美, 本田茉也, 山田洋介, 竹内康英, 高田正泰, 戸井雅和, et al. 高解像度拡散強調画像とT1/T2強調画像を用いた非造影MRIによる乳房病変の診断アルゴリズム. 日本乳癌学会学術総会プログラム・抄録集. 2022. 30th (CD-ROM)
more...
Lectures and oral presentations (1):
-
Management of Residual Disease after Neo-adjuvant CT in Her2 neu positive Breast Cancer.
(2019)
Return to Previous Page